Awareness Campaigns by Governments Can Drive Global Carotid Artery Disease Market till 2023

Carotid arteries are blood vessels in the neck which supply oxygen to the brain. Carotid artery disease (CAD) is a medical condition in which plaques in the blood vessels prevent oxygen supply and cause strokes. Various medicines are used for reducing the plaque amount or surgical techniques are employed by doctors to help restore normal blood flow. The global carotid artery disease market report compiled by analysts at Market Research Future (MRFR) outlines the various drivers, challenges, and opportunities faced by the players during the period of 2017 to 2023.

Carotid Artery Disease Market Overview

The global carotid artery disease market is slated to display a CAGR of 4.1% from 2017 to 2023 (forecast period). It can touch a value of USD 11,621.6 million by 2023. The growing geriatric populace, the rising adoption of unhealthy lifestyles by patients, and sales of over-the-counter (OTC) drugs are main drivers of the market. Efforts by pharmaceutical manufacturers for the production of therapeutic drugs can facilitate market growth.

The rise of tobacco consumption is likely to warrant the demand in the market till the end of the forecast period. According to the World Health Organization (WHO), strokes accounted for 17 million annually. The demand for preventive diagnosis and treatment methods for CAD can bode well for the market till 2023. Medications prescribed for the treatment of CAD include tissue plasminogen activator (tPA), anticoagulant medications, and antiplatelet medications.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6301

Awareness campaigns by governments and pharma firms for enlightening patients and raising sufficient wherewithal are predicted to bolster the market demand. But high cost of these medications and surgical options are challenges faced by the market.

Carotid Artery Disease Market Segmentation

The global carotid artery disease treatment market is segmented by diagnosis & treatment and end-user.

By diagnosis & treatment, it is segmented into diagnosis and treatment. The treatment segment is divided into medications and surgical procedures. Medications comprise antihypertensive drugs, antiplatelet drugs, and cholesterol-lowering statins. On the other hand, surgical procedures encompass carotid artery bypass, carotid artery angioplasty & stenting, and carotid endarterectomy.

By end-user, it is segmented into hospitals & clinics, pharmacies, ambulatory & surgical centers, and others.

Regional Analysis

Asia Pacific (APAC), the Americas, Europe, and the Middle East & Africa (MEA) are the regions discussed with respect to the market report.

The Americas accounted for 37.8% share of the global carotid artery disease market in 2017. Factors driving the regional market growth include supportive regulations for drug development, rising prevalence of chronic diseases, and rising levels of cholesterol in patients. According to the 2014 report by Surgeon General, close to 400,000 patients with ages of 70 and above suffered from asymptomatic carotid artery stenosis.

The Europe carotid artery disease market is anticipated to expand its share globally due to increased healthcare spending of patients, increased healthcare budget of economies, government funding for research on chronic diseases, and growth in the biopharmaceutical sector. Rising number of diabetics in the region can drive the market growth. This is supported by the rising number of diabetics purported to touch 59.8 million in 2015, as per the report by the World Diabetes Foundation Organization.

The APAC region is expected to expand due to considerable investments by major players, development of new healthcare infrastructure, subsidies given to producers, and the large number of research organizations. India possesses the potential of generating maximum revenue to the region due to the large number of clinical trials. In addition, the mushrooming of contract research organizations to cater to the needs of major pharmaceutical and biopharmaceutical firms can bode well for the market.

Carotid Artery Disease Market Competition Outlook

Silk Road Medical, Inc., Boston Scientific Corporation, Stryker Corporation, Medtronic, Cardinal Health, Terumo Corporation, Hitachi, Ltd, Becton, Dickinson and Company, Abbott, W. L. Gore & Associates, Inc., and others are noteworthy participants of the global carotid artery disease market. Product approvals of latest products by federal agencies can bode well for these players.

Carotid Artery Disease Industry News

Carotid artery imaging is a brand new diagnostic procedure as per the new findings in the Journal of Computer-assisted Tomography. The study concluded its efficacy in determining the presence of cardiovascular diseases and preventing the probability of strokes.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/carotid-artery-disease-market-6301

Doxorubicin Market to Register Striking Growth | Growth rate of 6.5% By 2023

Doxorubicin Market Analysis

The global doxorubicin market is projected to have a steady growth rate at a whopping 6.5% CAGR over the forecast period (2016-2023). Doxorubicin or anthracycline is a form of chemotherapy medicine that is used for diminishing or reducing growth of cancer cells via blocking the topo isomerase enzyme. This drug is utilized alone or together with other drugs for treating various types of cancers such as ovarian, stomach, bladder, lung, breast, non-Hodgkin and Hodgkin lymphomas, neuroblastoma and specific forms of leukemia. The treatment rests upon the cancer type being treated, how well a patient responds to the medicine and other forms of drugs that the patient takes at the time of the treatment. Doxorubicin comes in both lyophilized power form and injection solution. It is generally administered intravenously through central venous catheters (CVC) or peripheral inserted central line catheters (PICC).

There are abundant factors that is propelling the growth of the doxorubicin market. These factors as per the MRFR (Market Research Future) report include increasing prevalence of various forms of cancer, boost in geriatric population, growing awareness of cancer treatment and inclusion of the drug in different applications such as AIDS-related Kaposi Sarcoma and neuroblastoma, growing cancer treatment awareness programs, large presence of ablation and surgical centers and technological advancements. On the contrary stringent regulatory authorities, various cost suppression measures undertaken by different governments and numerous side effects resulting from doxorubicin are factors that are likely to hamper the growth of the doxorubicin market. Some of the common side effects of taking doxorubicin include inflammation of the mouth, rash, vomiting, bone marrow suppression, hair loss, allergic reactions namely anaphylaxis, damage of tissue owing to the position of the injection, heart damage, treatment associated to leukemia and radiation recall. All these side effects and more are affecting the doxorubicin market growth.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7376

Doxorubicin Market Segmentation

MRFR report offers a broad segmental analysis of the doxorubicin market on the basis of application and distribution channel.

Based on application, the doxorubicin market is segmented into leukemia, ovarian cancer, stomach cancer, prostate cancer, bone sarcoma, breast cancer, gastric cancer, liver cancer and others. Of these, prostate and breast cancer will have the largest share in the market over the forecast period.

Based on distribution channel, the doxorubicin market is segmented into retail pharmacy, hospital pharmacy and others. Of these, hospital pharmacy is projected to lead the market over the forecast period.

Regional Analysis

By region, the doxorubicin market covers growth opportunities and latest trends across Americas, the Middle East and Africa, Europe and Asia Pacific. Of these, the Americas will remain the vital contributor in the market over the forecast period. Factors attributed for the market growth in this region include favorable regulatory authorities and reimbursement, awareness about cancer treatment, increase in cancer cases and presence of leading manufacturers. The doxorubicin market in Europe will account for the second major share owing to rising healthcare expenditure and increasing pool of cancer patients. In the APAC region, the doxorubicin market is projected to grow at the fastest pace over the forecast period. This is on account of growing geriatric population especially in China and India, growing number of manufacturers looking for opportunities in developing countries, government investment and initiatives for the healthcare sector development and increasing cancer treatment awareness programs. On the other hand, the doxorubicin market in the Middle East and Africa is prognosticated to have minimal share over the forecast period.

Doxorubicin Market Key Players

Leading players profiled in the doxorubicin market include GLENMARK PHARMACEUTICALS LTD, Teva Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Sandoz, Novartis AG, Accord Healthcare, Janssen Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Pfizer, Inc, and various others.

March 2019 - SourcingLink.net, Inc. (SNET) has lately revealed the news of entering into a worldwide exclusive licensing agreement with leading biopharmaceutical company, NanoSmart Pharmaceuticals, Inc. This agreement has been made for the right of utilizing nanoparticle platform technologies of NanoSmart for developing and commercializing doxorubicin’s improved formulations to treat human cancers. It will impact countless cancer patients all across the world and also offer the increasing global cancer population with enhanced therapy options, including patients with unmet rare cancer needs.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/doxorubicin-market-7376

Anesthesia Machines Market to Rise at 7.8% CAGR due to Growing Demand for Surgeries

Anesthesia Machine Market Insight

Market Research Future (MRFR) has announced the release of a new research study that analyzes the global anesthesia machines market and provides insights into the market’s probable growth trajectory over the forecast period (2016-2023). The economic landscape of the global anesthesia machines market is assessed in detail in the report, which also contains a detailed analysis of the main drivers and restraints operating on the market. The segmentation of the global anesthesia machines market is profiled in detail to provide readers with a comprehensive view of the global market’s hierarchy by various criteria. The competitive landscape of the global anesthesia machines market is also analyzed in the report to provide pointers as to the leading players and successful strategies in the market. According to the study, the global anesthesia machines market is expected to rise to a value of USD 14.75 billion by 2023, rising at a CAGR of 7.8% over the forecast period. The global anesthesia machines market was valued at USD 9.4 billion in 2016.

The growing number of surgeries is the prime driver for the global anesthesia machines market. The rising prevalence of chronic diseases as well as trauma cases is thus likely to be a major driver for the anesthesia machines market over the forecast period. The increasing awareness about the efficacy and utility of anesthesia machines has resulted in their growing adoption in the healthcare sector. Surgeries pertaining to the nervous system, cardiovascular system, urinary system, digestive system, and the musculoskeletal system are likely to become increasingly prevalent in recent years, which has driven the demand for anesthesia machines at a steady rate. Computerized anesthesia machines are likely to become more prevalent in the global market over the forecast period due to their benefits in terms of better precision and accurate monitoring.

Increasing research into the portability and miniaturization of anesthesia machines is likely to lead to growth of the anesthesia machines market over the forecast period. Innovations to make surgeries more comfortable and simpler for surgeons are proving popular in the healthcare sector at the moment, resulting in steady growth of the anesthesia machines market. On the other hand, the risks of infection and high costs are likely to hamper the growth prospects of the global anesthesia machines market over the forecast period. The risk of infection in anesthesia machines is being highly researched in order to improve the hygiene-related aspects of anesthesia machines. This could result in steady technological progression in the coming years, rectifying one of the major restraints against the anesthesia machines market.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6179

Segmental Analysis:

The global anesthesia machines market is segmented on the basis of type, clinical indication, subject, component, form, end use, and region. The comprehensive assessment of the segmentation of the global anesthesia machines market helps provide a clear view of the market to readers.

On the basis of type, the global anesthesia machines market is segmented into continuous anesthesia machines, intermittent anesthesia machines, and others. Continuous anesthesia machines held a dominant share of 58% in the global anesthesia machines market in 2016 and are likely to remain the major contributor to the global market over the forecast period.

On the basis of clinical indication, the global anesthesia machines market is segmented into nervous system surgeries, ENT surgeries, respiratory system surgeries, cardiovascular system surgeries, digestive system surgeries, urinary system surgeries, musculoskeletal system surgeries, skin surgeries, and others.

By subject, the global anesthesia machines market is segmented into human and veterinarian.

By component, the global anesthesia machines market is segmented into machines, ventilators, monitors, disposables, and others.

By form, the anesthesia machines market is segmented into portable and standalone anesthesia machines.

By end use, the global anesthesia machines market is segmented into hospitals, point of care units, and others.

Regional Analysis:

Regionally, Asia Pacific is expected to exhibit the highest growth in the global anesthesia machines market over the forecast period due to the intensive efforts taken by governments in the region to improve the healthcare sector and increasing investment in the healthcare sector.

The Middle East and Africa is also likely to be a major regional market for anesthesia machines over the forecast period, due to the improving performance of the market in countries such as Qatar, the UAE, Kuwait, and Saudi Arabia.

North America holds the dominant share in the global anesthesia machines market at present and is likely to remain a major contributor over the forecast period.

Competitive Analysis:

Leading players in the global anesthesia machines market include Heyer Medical AG, Koninklijke Philips NV, GE Healthcare, Smiths Medical, Teleflex Inc., Mindray DS USA Inc., Covidien, Draeger, and Fisher & Paykel Healthcare.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/upcoming-reports/anesthesia-machine-market-6179

Medical Waste Management Equipment Market Dominated by North America, U.S. to Dominate Global Proceedings

Medical Waste Management Equipment Market Analysis

Global medical waste management equipment market is studied in detail in the latest report from Market Research Future (MRFR). The historical trajectory of the global medical waste management equipment market is studied in the report along with an analysis of the market’s leading drivers and restraints, which are responsible for the way the market develops over the coming years. The leading segments and key players in the global medical waste management equipment market are also profiled in the report in order to give readers a clear idea about the market’s internal dynamics.

The global medical waste management equipment market has taken on a key role in the global healthcare sector in recent years due to the growing scope of the healthcare and research sectors, which has led to a steady increase in the volume of medical waste generated around the world. The presence of bioactive compounds in medical waste makes its management an even higher priority, as the bioactive compounds can spread diseases and disturb the ecological balance if not handled correctly.

Growing government support to the use of advanced medical waste management protocol is likely to be a major driver for the medical waste management equipment market over the forecast period. The presence of strict regulations mandating proper cleanup and management of medical waste has led to widespread action among the healthcare industry players in developed regions such as North America and Western Europe. Several governments in developed regions have come up with monetary penalties for improper handling of medical waste, which has incentivized major market players to come up with comprehensive solutions for adequate and safe management of medical waste. This is likely to be a major driver for the medical waste management equipment market over the forecast period, as the growth of the healthcare sector and medical research sector is likely to continue unabated over the forecast period, especially in developed countries such as the U.S., the UK, Germany, and France.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1952

Medical Waste Management Equipment Market Segmentation:

The global medical waste management equipment market is segmented on the basis of type of waste, type of product, method of management, and region.

By type of waste, the global medical waste management equipment market is segmented into infectious waste, non-infectious/hazardous waste, radioactive waste, and medical disposables.

On the basis of product type, the global medical waste management equipment market is segmented into autoclaves, microwaves, sterilization equipment, and others. Autoclaves hold the largest share in the global medical waste management equipment market and are likely to retain a dominant share in the market over the forecast period.

By method of management, the global medical waste management equipment market is segmented into recycling, mechanical/chemical disinfection, disposal, irradiation, and others.

Medical Waste Management Equipment Market Regional Analysis:

North America is likely to dominate the global medical waste management equipment market over the forecast period due to the strong presence of government regulations supporting and mandating effective medical waste management procedures. The ecological viability of the medical waste management procedures is also a major factor in the medical waste management equipment market’s growth in North America, as several companies have faced political and popular opposition due to the supposedly anti-environmental impact of their processes. However, the U.S. remains the major country-level market for the global medical waste management equipment market and is likely to remain in the position over the forecast period due to the growing scope of the healthcare sector in the region and the rising volume of medical waste.

Europe also holds a significant share in the global medical waste management equipment market and is likely to hold a leading share in the global market over the forecast period due to the growing emphasis on the environmental impact of medical waste management processes in the region. Developing environmentally viable procedures for medical waste disposal is likely to be a fruitful strategy for players operating in the Europe medical waste management equipment market.

Medical Waste Management Equipment Market Competitive Analysis:

Leading players in the global medical waste management equipment market include MedPro Medical Waste Disposal, Waste Management Inc., Stericycle Inc., Republic Services Inc., and Clean Harbors.

Industry Updates:

In February 2019, Stericycle decided to leave the state of Utah in the face of sustained political and popular opposition from environmental activists to some of Stericycle’s processes.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/medical-waste-management-equipment-market-1952

Increasing Instances of Ulcerative Colitis in The North America Makes It a Lucrative Market for the Ulcerative Colitis Cure Providers

Ulcerative Colitis Market Overview

As per the reports published by Market Research Future (MRFR), the worldwide ulcerative colitis market has been recorded as a growing market. The market can be estimated to generate remarkable worth in the coming future. Ulcerative colitis is a category of inflammatory bowel disease (IBD) that mostly impacts the lower region of the body such as the rectum and sigmoid colon. Diarrhea, bleeding from the rectum, belly pain, and cramps are some of the common signs of ulcerative colitis. As per the studies conducted by the Centers for Disease Control, global prevalence of ulcerative colitis has been recorded to be witnessing 0.5 to 24.5 cases per 100,000 people every year. Chances of recurrence of the ailment’s signs is also high. The Colitis Foundation of America stated that almost 30% of people on remission are likely to suffer from the ailment seethe in the future, right after the cure and remission.

Another study published by the American Family Physician stated that ulcerative colitis impacts between 250,000 and 500,000 individuals in the United States, with a yearly prevalence of 2 to 7 per 100,000 people. Ulcerative colitis primarily impacts the large intestine. Additionally, it might also affect the joints, skin, and eyes. The colon gets inflamed when affected by ulcerative colitis. In extreme instances, ulcers are formed on the edges of the colon. The ulcers often produce mucus, pus, and in severe cases it might bleed. The rectum being the conclusion of the colon gets always involved in ulcerative colitis. The ailment is called ulcerative proctitis, if the inflammation has only taken place in the rectum. However, the inflammation is likely to affect the upper areas of the colon. Pancolitis or universal colitis is the condition when the entire colon is affected. The precise cause that triggers ulcerative colitis has not been found yet. 

Doctors used to assume stress and irregular diet are the two major reasons causing ulcerative colitis. But of late, doctors have concluded that these factors are likely to worsen the ailment but they can't cause it at the first place. Key factors propelling the market growth majorly includes the rising instances of ulcerative colitis, improved cure of inflammatory bowel ailments, arrival of enhanced drugs, creating patient pool with unmet requirements, novel drugs entering the market, surging global incidence & prevalence rate, soaring outlays towards research in small molecules, and remarkable investments in the entire R&D programs. Blockbuster drugs are gradually losing patent protection. Besides, they are surging the propensity for generic drugs which can limit the market growth. The lack of personalized therapy, medication, and curative therapy are the major opportunities for the prosperity of the market. 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2354

Ulcerative Colitis Market Segmentation

Global ulcerative colitis market has been segmented based on medication and type. Based on medication the market has been segmented into steroids, 5-aminosalicylates, immunomodulators, biologics, and purine analogs. Biologics are estimated to hold the largest market share. Steroids drugs are likely to expand at the highest CAGR over the forecast period. Based on types, the market has been segmented as proctosigmoiditis, ulcerative proctitis, pancolitis or universal colitis, fulminant colitis, and left-sided colitis. Ulcerative proctitis has been estimated to hold the largest market share over the forecast period.

Regional Analysis

In 2016, North America was projected to account for the largest share of the worldwide ulcerative colitis market followed by Europe. The region is likely to continue dominating the pack over the forecast period. In the Asia-Pacific region, China leads the ulcerative colitis market. Improvement of healthcare facilities coupled with economic development are accelerating the development of the market.

Ulcerative Colitis Market Key Players 

Global ulcerative colitis market has been dominated by key players such as AbbVie Inc., Allergan, Inc., UCB S.A., Pfizer Inc., Takeda Pharmaceutical Company Limited, Ferring B.V., Bayer AG, Perrigo Company plc,  Janssen Biotech, Merck, and Johnson & Johnson Services, Inc.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/ulcerative-colitis-market-2354